1OOO Youngs Road  |  Suite 21O
Buffalo NY 14221 USA
716.431.5757 Fax
Looking for KSL Biomedical? Click HERE.
  • LinkedIn Social Icon
  • Twitter

IBD patients,

don't miss your Window of Opportunity.


Introducing PredictSURE IBD™ — the first validated prognostic test for Crohn's disease and ulcerative colitis.


PredictSURE IBD™

The first step towards personalized medicine in IBD

A simple, CE-marked, whole blood test, providing long-term prognostic data that can guide clinical management in inflammatory bowel disease (Crohn’s disease and ulcerative colitis). 

Patient Resources

HMOs and
Lab Partners

Healthcare Professionals

Award-winning PredictSURE IBD™ is the world’s first validated and CE-marked prognostic test for guiding treatment options in inflammatory bowel disease (Crohn’s disease and ulcerative colitis). PredictSURE IBD™ is based upon 10 years of extensive research on gene expression profiling of CD8+ T cells. This whole blood-based biomarker test is a major step towards personalized medicine in IBD.


PredictSURE IBD™ is a biomarker test combined with a sophisticated, proprietary algorithm that will tell you the likely course of your newly diagnosed patients’ IBD; differentiating between an aggressive or milder form of the disease. All you need is a small blood sample from your patients (16+ years) and an on-line account for rapid, on-line reporting. With PredictSURE IBD™ you can take control of Crohn’s disease and ulcerative colitis treatment options.